Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.000
-0.090 (-8.26%)
Nov 4, 2024, 4:00 PM EST - Market closed
Biofrontera Stock Forecast
BFRI's stock price has decreased by -77.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Biofrontera stock has a target of 7.00, which predicts an increase of 600.00% from the current stock price of 1.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 16, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Biofrontera is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +600.00% | Aug 16, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,700.00% | Aug 31, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $140 → $18 | Strong Buy | Maintains | $140 → $18 | +1,700.00% | Jul 5, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +13,900.00% | May 15, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +13,900.00% | Mar 9, 2023 |
Financial Forecast
Revenue This Year
40.58M
from 34.07M
Increased by 19.11%
Revenue Next Year
48.76M
from 40.58M
Increased by 20.16%
EPS This Year
-3.28
from -13.02
EPS Next Year
-0.88
from -3.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 43.0M | 52.1M | 63.1M | ||
| Avg | 40.6M | 48.8M | 61.3M | ||
| Low | 37.8M | 45.1M | 58.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.3% | 28.4% | 29.4% | ||
| Avg | 19.1% | 20.2% | 25.7% | ||
| Low | 11.0% | 11.1% | 20.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.22 | -0.49 | 0.05 |
| Avg | -3.28 | -0.88 | 0.05 |
| Low | -3.29 | -1.23 | 0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.